Table 4. Comparison of in-hospital events of groups.
Low glucose group (n = 457) | High glucose group (n = 220) | P | |
Death | 23 (5%) | 41 (18%) | < 0.001 |
Re-infarction | 10 (2%) | 6 (2.7%) | 0.66 |
TVR | 19 (4%) | 14 (5.4%) | 0.21 |
MACE | 38 (8%) | 49 (22.2%) | < 0.001 |
Stroke | 5 (1%) | 8 (3.6%) | 0.02 |
CPR | 24 (5.2%) | 47 (21.3%) | < 0.001 |
Hemodialysis | 4 (0.8%) | 7 (3.1%) | 0.03 |
VT/VF | 14 (3%) | 40 (18.1%) | < 0.001 |
CHF | 78 (17%) | 72 (32.7%) | < 0.001 |
Inotrope use | 41 (8.9%) | 56 (25.5%) | < 0.001 |
IABP | 9 (1.9%) | 45 (20.5%) | < 0.001 |
Atrial fibrillation | 21 (4.5%) | 10 (4.5%) | 0.06 |
Transient pacemaker | 21 (4.5%) | 24 (10.9%) | 0.002 |
Transfusion | 31 (6.7%) | 23 (10.5%) | 0.09 |
Hospital in-stay (day) | 7.7 ± 4.3 | 8.6 ± 6.1 | 0.04 |
Variables are reported as mean ± SD or n (%). CPR: cardio-pulmonary resuscitation; IABP: intra-aortic balloon pump; MACE: major adverse cardiac event; TVR: target vessel revascularization, VT/VF; ventricular tachycardia/ventricular fibrillation.